Live feed
Filing
SC 13D
SC 13D0001104659-21-082084·Janux Therapeutics, Inc.
Schedule 13D ownership disclosure
Janux Therapeutics Inc
Security class unavailable · CUSIP: 47103J105
Event date: 2021-06-15
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 8,670,644
- Percent of class
- 20.8000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-21-082084
- Form type
- SC 13D
- Filer
- Janux Therapeutics, Inc.
- CIK
- CIK 1817713
- Filed
- Jun 16, 2021
- Reporting period
- Jun 15, 2021
- Description
- Schedule 13D beneficial ownership